MedTrace Logo

BostonGene-Integrated Genomic Registry (BIGR)

NCT04991922 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-02-07

No results posted yet for this study

Summary

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Conditions

  • Malignancy

Sponsors & Collaborators

  • BostonGene

    lead INDUSTRY

Principal Investigators

  • Nathan Fowler · BostonGene

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2031-07-01
Completion
2036-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04991922 on ClinicalTrials.gov